# Sexual Dysfunction in Gynecologic Oncology Patients

> **NCT03801031** · PHASE4 · TERMINATED · sponsor: **David Bender** · enrollment: 4 (actual)

## Conditions studied

- Gynecologic Cancer
- Sexual Dysfunction

## Interventions

- **DRUG:** Lidocaine Topical
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03801031
- **Lead sponsor:** David Bender
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-06
- **Primary completion:** 2021-11-03
- **Final completion:** 2021-11-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2022-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801031, "Sexual Dysfunction in Gynecologic Oncology Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03801031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*